Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on computer-aided drug design

R C Jackson1

  • 1Agouron Pharmaceuticals Inc, San Diego, USA.

Current Opinion in Biotechnology
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Computational drug design, using quantitative structure-activity relationship and structure-based strategies, is advancing rapidly. New algorithms and protein structures are facilitating the development of drugs currently in clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A QUANTITATIVE CYTOGENETIC ANALYSIS OF AN INTERSECTIONAL HYBRID IN HELIANTHUS (COMPOSITAE).

American journal of botany·2018
Same author

CHROMOSOMAL EVOLUTION IN HAPLOPAPPUS GRACILIS: A CENTRIC TRANSPOSITION RACE.

Evolution; international journal of organic evolution·2017
Same author

Colchicine induced quadrivalent formation in Helianthus: evidence of ancient polyploidy.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Quantitative analysis of diploid translocation heterozygotes: test of models and equations.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Heterochromatin differentiation and phylogenetic relationship of the A genomes in diploid and polyploid wheats.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Cortical fMRI activation to opponents' body kinematics in sport-related anticipation: expert-novice differences with normal and point-light video.

Neuroscience letters·2011
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Area of Science:

  • Computational chemistry
  • Medicinal chemistry
  • Drug discovery

Background:

  • Significant advancements in computational methods are revolutionizing drug design.
  • Numerous pharmaceutical targets, including proteins with bound inhibitors, have had their structures elucidated.
  • Progress in algorithms for de novo design, ligand docking, and binding energy scoring continues.

Purpose of the Study:

  • To highlight recent progress in computational drug design methodologies.
  • To underscore the impact of new structural data on drug discovery.
  • To report on the development of advanced algorithms for molecular design and interaction prediction.

Main Methods:

  • Quantitative structure-activity relationship (QSAR) approaches.
  • Structure-based drug design strategies.

Related Experiment Videos

  • Development of novel algorithms for de novo design, ligand docking, and binding energy scoring.

    • Main Results:

    • New protein structures relevant to drug development have been determined.
    • Algorithms for de novo design, docking, and scoring have shown continued improvement.
    • Several computationally designed drugs are progressing through clinical trials.

    Conclusions:

    • Computational methods are increasingly integral to modern drug discovery.
    • The integration of structural biology and computational chemistry accelerates therapeutic development.
    • The successful progression of computationally designed drugs validates these advanced approaches.